This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Align Technology, based in California, manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided manufacturing) digital services used in dentistry, orthodontics, and dental records storage. The clear aligner system corrects malocclusion using nearly invisible and removable appliances that gently move the tooth to a desired final position.
SmileDirectClub (SDC) Up 1.5% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
SmileDirectClub (SDC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Align Technology (ALGN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed the most recent trading day at $269.01, moving -1.68% from the previous trading session.
Align Technology (ALGN) Down 9.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Bear of the Day: Align Technology (ALGN)
by Jeremy Mullin
Bears continue to show big smiles when looking at this medical name.
Malibu Boats and Align Technology have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Malibu Boats and Align Technology have been highlighted as Zacks Bull and Bear of the Day.
New Strong Sell Stocks for May 25th
by Zacks Equity Research
ALGN, AUD, and BDX have been added to the Zacks Rank #5 (Strong Sell) List on May 25, 2022.
Align Technology (ALGN) to Offer Asana Smiles With New Pact
by Zacks Equity Research
Align Technology's (ALGN) new partnership will give doctors access to an alternative that helps reduce manual processes and creates a clear view of Invisalign treatment workflows.
Align Technology (ALGN) Debuts Invisalign Outcome Simulator Pro
by Zacks Equity Research
The next-generation of Align Technology's (ALGN) advanced patient communication tool will help patients see their potential new smile after Invisalign treatment.
Do Options Traders Know Something About Align Technology (ALGN) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Align Technology (ALGN) stock based on the movements in the options market lately.
Cadence Design Systems and Align Technology have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Cadence Design Systems and Align Technology are part of the Zacks Bull and Bear of the Day article.
Bear of the Day: Align Technology (ALGN)
by Kevin Cook
Global growth slowdown has slashed EPS another 19% this year, but keep this dental innovator on your radar
Align Technology (ALGN) Q1 Earnings Lag Estimates, Margins Fall
by Zacks Equity Research
Robust Clear Aligner case volume growth and increased uptake of the iTero Element 5D Plus are driving Align Technology's (ALGN) first-quarter top line.
Align Technology (ALGN) Q1 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Align Technology (ALGN) delivered earnings and revenue surprises of -4.91% and 2.86%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Medical Device Stock Earnings Roster for Apr 27: BSX, HOLX & More
by Riya Anand
Medical device stocks' Q1 earnings will likely reflect rebound in base business. Let's see how Boston Scientific (BSX), Hologic (HOLX), Align Technology (ALGN) and Integra (IART) will fare in Q1.
Why Align Technology (ALGN) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Why Earnings Season Could Be Great for Align Technology (ALGN)
by Zacks Equity Research
Align Technology (ALGN) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Align Technology (ALGN) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Robust demand for iTero scanners and increasing Invisalign case submissions are expected to have contributed to Align Technology's (ALGN) Q1 performance.
Analysts Estimate Align Technology (ALGN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Align Technology (ALGN) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed at $409.82 in the latest trading session, marking a -1.7% move from the prior day.
Align Technology (ALGN) Stock Moves -1.4%: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed the most recent trading day at $436, moving -1.4% from the previous trading session.
Here's Why You Should Hold on to Align Technology (ALGN) Now
by Zacks Equity Research
Investors are optimistic about Align Technology (ALGN) on the growing market adoption of the iTero Element 5D Plus imaging system.
Align Technology (ALGN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed the most recent trading day at $436.26, moving -0.18% from the previous trading session.
Align Technology (ALGN) Debuts Latest Feature for ClinCheck
by Zacks Equity Research
Align Technology's (ALGN) CBCT integration feature for ClinCheck will enable doctors to treat a broader range of cases with the Invisalign clear aligners.
Align Technology (ALGN) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed at $425.48 in the latest trading session, marking a +1.15% move from the prior day.
Align Technology (ALGN) Down 5.1% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.